17 reports of this reaction
1.6% of all FERROSOFERRIC PHOSPHATE reports
#14 most reported adverse reaction
MUSCLE SPASMS is the #14 most commonly reported adverse reaction for FERROSOFERRIC PHOSPHATE, manufactured by DNA Labs. There are 17 FDA adverse event reports linking FERROSOFERRIC PHOSPHATE to MUSCLE SPASMS. This represents approximately 1.6% of all 1,043 adverse event reports for this drug.
Patients taking FERROSOFERRIC PHOSPHATE who experience muscle spasms should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
MUSCLE SPASMS is a less commonly reported adverse event for FERROSOFERRIC PHOSPHATE, but still significant enough to appear in the safety profile.
In addition to muscle spasms, the following adverse reactions have been reported for FERROSOFERRIC PHOSPHATE:
The following drugs have also been linked to muscle spasms in FDA adverse event reports:
MUSCLE SPASMS has been reported as an adverse event in 17 FDA reports for FERROSOFERRIC PHOSPHATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
MUSCLE SPASMS accounts for approximately 1.6% of all adverse event reports for FERROSOFERRIC PHOSPHATE, making it a notable side effect.
If you experience muscle spasms while taking FERROSOFERRIC PHOSPHATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.